Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer ( EV-309 )
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Enfortumab Vedotin
Related studies linked through entity extraction aliases.
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
- Status
- RECRUITING
- Phase
- PHASE2
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SYS6002 vs PADCEV in Patients With Advanced Urothelial Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of EV for Recurrent Endometrial Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
- Status
- RECRUITING
- Phase
- PHASE2
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Probiotics in Advanced Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
- Status
- RECRUITING
- Phase
- PHASE4
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
- Status
- RECRUITING
- Phase
- N/A
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
- Status
- RECRUITING
- Phase
- PHASE2
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2